Evidence map›Paper›PMID 27303377›Full record

ArticleFrontiers in microbiology2016

Capturing One of the Human Gut Microbiome's Most Wanted: Reconstructing the Genome of a Novel Butyrate-Producing, Clostridial Scavenger from Metagenomic Sequence Data.

Patricio Jeraldo, Alvaro Hernandez, Henrik B Nielsen, Xianfeng Chen, Bryan A White, Nigel Goldenfeld, Heidi Nelson, David Alhquist, Lisa Boardman, Nicholas Chia

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes.Annals of clinical and translational neurology · 2020
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Meat Intake and the Dose of Vitamin BInternational journal of tryptophan research : IJTR · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Patricio JeraldoMicrobiome Program, Center for Individualized Medicine, Mayo Clinic, RochesterMN, USA; Department of Surgery, Mayo Clinic, RochesterMN, USA; Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, UrbanaIL, USA.
Alvaro HernandezRoy J. Carver Biotechnology Center, University of Illinois at Urbana-Champaign, Urbana IL, USA.
Henrik B NielsenCenter for Biological Sequence Analysis, Department of Systems Biology, Technical University of Denmark Kongens Lyngby, Denmark.
Xianfeng ChenDepartment of Health Sciences Research, Mayo Clinic, Rochester MN, USA.
Bryan A WhiteCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, UrbanaIL, USA; Department of Animal Sciences, University of Illinois at Urbana-Champaign, UrbanaIL, USA.
Nigel GoldenfeldCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, UrbanaIL, USA; Department of Physics, University of Illinois at Urbana-Champaign, UrbanaIL, USA.
Heidi NelsonMicrobiome Program, Center for Individualized Medicine, Mayo Clinic, RochesterMN, USA; Department of Surgery, Mayo Clinic, RochesterMN, USA.
David AlhquistDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester MN, USA.
Lisa BoardmanDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester MN, USA.
Nicholas ChiaDivision of Gastroenterology and Hepatology, Mayo Clinic, RochesterMN, USA; Division of Gastroenterology and Hepatology, Mayo Clinic, RochesterMN, USA; Division of Gastroenterology and Hepatology, Mayo Clinic, RochesterMN, USA.

Funding

PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI GREGORY J. GORES · 2009 to 2026
$22.2M
Microbial Metabolic Toxicity Drives Colon CancerR01CA179243 · NCI · MAYO CLINIC ROCHESTER · PI CHIA, NICHOLAS · 2014 to 2018
$2.0M
NCI NIH HHS R01 CA179243NIDDK NIH HHS P30 DK084567
6 · The paper itself

Abstract

The role of the microbiome in health and disease is attracting great attention, yet we still know little about some of the most prevalent microorganisms inside our bodies. Several years ago, Human Microbiome Project (HMP) researchers generated a list of "most wanted" taxa: bacteria both prevalent among healthy volunteers and distantly related to any sequenced organisms. Unfortunately, the challenge of assembling high-quality genomes from a tangle of metagenomic reads has slowed progress in learning about these uncultured bacteria. Here, we describe how recent advances in sequencing and analysis allowed us to assemble "most wanted" genomes from metagenomic data collected from four stool samples. Using a combination of both de novo and guided assembly methods, we assembled and binned over 100 genomes from an initial data set of over 1,300 Gbp. One of these genome bins, which met HMP's criteria for a "most wanted" taxa, contained three essentially complete genomes belonging to a previously uncultivated species. This species is most closely related to Eubacterium desmolans and the clostridial cluster IV/Clostridium leptum subgroup species Butyricicoccus pullicaecorum (71-76% average nucleotide identity). Gene function analysis indicates that the species is an obligate anaerobe, forms spores, and produces the anti-inflammatory short-chain fatty acids acetate and butyrate. It also appears to take up metabolically costly molecules such as cobalamin, methionine, and branch-chained amino acids from the environment, and to lack virulence genes. Thus, the evidence is consistent with a secondary degrader that occupies a host-dependent, nutrient-scavenging niche within the gut; its ability to produce butyrate, which is thought to play an anti-inflammatory role, makes it intriguing for the study of diseases such as colon cancer and inflammatory bowel disease. In conclusion, we have assembled essentially complete genomes from stool metagenomic data, yielding valuable information about uncultured organisms' metabolic and ecologic niches, factors that may be required to successfully culture these bacteria, and their role in maintaining health and causing disease.

Indexed as

binningButyricicoccusgenome assemblymetagenomicsmicrobiome

Identifiers

PMID27303377
PMCPMC4880562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.